~~ Session #3 - Drug Discovery at Amgen: A Multi‐Modality Approach ~~

We will introduce Amgen’s broad toolkit of drug modalities and describe how we choose the “right” modality for drug discovery, focusing on biologic medicines.

Speaker: Roger A. Hart, PhD
Roger Hart is a Scientific Director in Process Development and his work is focused on innovation within Amgen and with external academic collaborators. After working in biotechnology for almost 3 decades, he has participated in most aspects of the lifecycle of development for many modalities and numerous clinical and commercial drugs.

Details About the Webinar

WEBINAR ENDED

About the Speaker

1601400084-deb023d151995fea Roger A. Hart
Scientific Director, Amgen

Roger Hart is a Scientific Director in Process Development and his work is focused on innovation within Amgen and with external academic collaborators. After working in biotechnology for almost 3 decades, he has participated in most aspects of the lifecycle of development for many modalities and numerous clinical and commercial drugs.

Education:
- BS Biomedical Engr. Univ. NM (1985)
- PhD Biochemical Engr. Caltech (1991)

Work:
- Genetech Inc. (1991-1996)
- Amgen Inc. (1996-present)

Speciality:
- Biopharmaceutical Process Development
- Innovation, External Engagment

Registration is full. If you have already registered, please log in or use the link from your registration confirmation email.
Powered by BigMarker